Trial Profile
A retrospective study evaluating the efficacy of different doses and effect of Transarterial chemoembolization during and after Sorafenib discontinuation in patients with hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 27 Nov 2016 New trial record